Health
Trial ALS drug shows potential to drag out patient endurance – Microbioz India
An experimental medicine that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s d…
An experimental medicine that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, has now demonstrated the capacity to also prolong patient survival. The findings come from a clinical trial conducted by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH) and Amylyx Pharmaceuticals, Inc., the company that produces the medication. Amylyx developed AMX0035, the inve…
-
Noosa News24 hours agoCar of missing woman found west of Brisbane
-
Noosa News24 hours agoCar discovered in search for missing mother Tayla Spies last seen in rural Queensland two months ago
-
Business23 hours agoHow your ASX shares may be impacted by US tariffs
-
Noosa News23 hours agoSunshine Coast police saturate roads and beaches this Easter